One developer, China national pharmaceutical group, known as Sinopharm, said in November it applied for final market approval for use of its vaccine in China. More than 1 million people in China have received experimental vaccines under emergency use approval. Health officials previously said China will be able to manufacture 610 million doses by the end of 2020 and ramp up to 1 billion doses in 2021. It has built two facilities in China capable of producing 200 million doses per year. The company projects it will be able to produce a few hundred million doses of the vaccine by February or March of 2021.

Source: Dhaka Tribune December 06, 2020 06:22 UTC